Viatris Launch Plans Continue To Drag On, But Confidence High On Quartet
Firm Also Finalizing Strategy On GLP-1s; Chance To Go For 505(b)(2)s, Innovation
Viatris expressed confidence at the J.P. Morgan Healthcare Conference that it will hit its targets for complex injectables in 2025, while providing an update on its GLP-1 ambitions and its delinquent manufacturing facility in Indore, India.
